BNP PARIBAS ASSET MANAGEMENT Holding S.A. Has $10.45 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

BNP PARIBAS ASSET MANAGEMENT Holding S.A. grew its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 37.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 42,251 shares of the medical technology company's stock after acquiring an additional 11,553 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. owned about 0.09% of Teleflex worth $10,450,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Janus Henderson Group PLC raised its position in shares of Teleflex by 12.0% during the 1st quarter. Janus Henderson Group PLC now owns 5,409,317 shares of the medical technology company's stock valued at $1,223,424,000 after buying an additional 581,312 shares in the last quarter. Cooke & Bieler LP raised its holdings in shares of Teleflex by 23.3% during the second quarter. Cooke & Bieler LP now owns 912,797 shares of the medical technology company's stock valued at $191,989,000 after purchasing an additional 172,335 shares during the last quarter. TD Asset Management Inc raised its holdings in shares of Teleflex by 12.0% during the second quarter. TD Asset Management Inc now owns 456,081 shares of the medical technology company's stock valued at $95,928,000 after purchasing an additional 48,832 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in Teleflex by 6.6% during the second quarter. Bank of New York Mellon Corp now owns 425,647 shares of the medical technology company's stock valued at $89,526,000 after buying an additional 26,325 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Teleflex by 4.2% in the second quarter. Dimensional Fund Advisors LP now owns 398,175 shares of the medical technology company's stock worth $83,741,000 after purchasing an additional 15,992 shares during the period. 95.62% of the stock is owned by institutional investors.

Analysts Set New Price Targets

TFX has been the subject of a number of research reports. Stephens upped their target price on shares of Teleflex from $275.00 to $290.00 and gave the stock an "overweight" rating in a research report on Friday, August 2nd. Truist Financial reiterated a "hold" rating and set a $227.00 target price (down from $255.00) on shares of Teleflex in a report on Monday, November 4th. Royal Bank of Canada lowered their price target on shares of Teleflex from $275.00 to $245.00 and set an "outperform" rating on the stock in a report on Friday, November 1st. StockNews.com lowered shares of Teleflex from a "buy" rating to a "hold" rating in a research report on Wednesday. Finally, Mizuho decreased their target price on shares of Teleflex from $275.00 to $250.00 and set a "neutral" rating for the company in a research note on Friday, November 1st. Four equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $259.25.

Teleflex Trading Up 0.6 %

Shares of NYSE:TFX traded up $1.07 during trading on Friday, reaching $191.71. 309,439 shares of the stock were exchanged, compared to its average volume of 552,117. The firm's 50-day moving average price is $224.99 and its 200 day moving average price is $222.88. The firm has a market cap of $8.90 billion, a price-to-earnings ratio of 38.11, a price-to-earnings-growth ratio of 1.95 and a beta of 1.18. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a 12-month low of $185.66 and a 12-month high of $257.85.

Teleflex (NYSE:TFX - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts' consensus estimates of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. During the same period in the prior year, the business earned $3.64 EPS. The firm's revenue was up 2.4% on a year-over-year basis. On average, sell-side analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Shareholders of record on Friday, November 15th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.71%. The ex-dividend date is Friday, November 15th. Teleflex's payout ratio is currently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.